Logo image of OLK

OLINK HOLDING AB - ADR (OLK) Stock Fundamental Analysis

NASDAQ:OLK - Nasdaq - US6807101000 - ADR - Currency: USD

26.08  +0.08 (+0.31%)

After market: 26.02 -0.06 (-0.23%)

Fundamental Rating

3

OLK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 55 industry peers in the Life Sciences Tools & Services industry. OLK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OLK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year OLK has reported negative net income.
OLK had a negative operating cash flow in the past year.
In the past 5 years OLK always reported negative net income.
In the past 5 years OLK always reported negative operating cash flow.
OLK Yearly Net Income VS EBIT VS OCF VS FCFOLK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.21%, OLK is in line with its industry, outperforming 57.89% of the companies in the same industry.
The Return On Equity of OLK (-7.30%) is better than 64.91% of its industry peers.
Industry RankSector Rank
ROA -6.21%
ROE -7.3%
ROIC N/A
ROA(3y)-5.28%
ROA(5y)-5.94%
ROE(3y)-6.12%
ROE(5y)-8.05%
ROIC(3y)N/A
ROIC(5y)N/A
OLK Yearly ROA, ROE, ROICOLK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -2 -4 -6 -8 -10

1.3 Margins

OLK's Gross Margin of 66.88% is amongst the best of the industry. OLK outperforms 96.49% of its industry peers.
In the last couple of years the Gross Margin of OLK has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for OLK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.08%
GM growth 5YN/A
OLK Yearly Profit, Operating, Gross MarginsOLK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 -60

More info and screens

5

2. Health

2.1 Basic Checks

OLK does not have a ROIC to compare to the WACC, probably because it is not profitable.
OLK has more shares outstanding than it did 1 year ago.
The debt/assets ratio for OLK is higher compared to a year ago.
OLK Yearly Shares OutstandingOLK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
OLK Yearly Total Debt VS Total AssetsOLK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 23.79 indicates that OLK is not in any danger for bankruptcy at the moment.
OLK has a Altman-Z score of 23.79. This is amongst the best in the industry. OLK outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that OLK is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.05, OLK is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 23.79
ROIC/WACCN/A
WACC8.56%
OLK Yearly LT Debt VS Equity VS FCFOLK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 5.60 indicates that OLK has no problem at all paying its short term obligations.
With a decent Current ratio value of 5.60, OLK is doing good in the industry, outperforming 73.68% of the companies in the same industry.
A Quick Ratio of 3.91 indicates that OLK has no problem at all paying its short term obligations.
The Quick ratio of OLK (3.91) is better than 64.91% of its industry peers.
Industry RankSector Rank
Current Ratio 5.6
Quick Ratio 3.91
OLK Yearly Current Assets VS Current LiabilitesOLK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for OLK have decreased strongly by -145.45% in the last year.
The Revenue has grown by 18.16% in the past year. This is quite good.
The Revenue has been growing by 46.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
Revenue 1Y (TTM)18.16%
Revenue growth 3Y46.35%
Revenue growth 5YN/A
Sales Q2Q%4.71%

3.2 Future

Based on estimates for the next years, OLK will show a very strong growth in Earnings Per Share. The EPS will grow by 27.84% on average per year.
Based on estimates for the next years, OLK will show a quite strong growth in Revenue. The Revenue will grow by 17.43% on average per year.
EPS Next Y39.4%
EPS Next 2Y48.39%
EPS Next 3Y26.83%
EPS Next 5Y27.84%
Revenue Next Year13.93%
Revenue Next 2Y18.86%
Revenue Next 3Y16.25%
Revenue Next 5Y17.43%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OLK Yearly Revenue VS EstimatesOLK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100M 200M 300M 400M 500M
OLK Yearly EPS VS EstimatesOLK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OLK. In the last year negative earnings were reported.
OLK is valuated quite expensively with a Price/Forward Earnings ratio of 516.44.
OLK's Price/Forward Earnings ratio is in line with the industry average.
OLK is valuated expensively when we compare the Price/Forward Earnings ratio to 20.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 516.44
OLK Price Earnings VS Forward Price EarningsOLK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OLK Per share dataOLK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates OLK does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as OLK's earnings are expected to grow with 26.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.39%
EPS Next 3Y26.83%

More info and screens

0

5. Dividend

5.1 Amount

OLK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OLINK HOLDING AB - ADR

NASDAQ:OLK (7/9/2024, 9:30:55 PM)

After market: 26.02 -0.06 (-0.23%)

26.08

+0.08 (+0.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-13 2024-05-13/bmo
Earnings (Next)08-07 2024-08-07/amc
Inst Owners0.72%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.24B
Analysts49.09
Price Target26.52 (1.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-62.11%
Min EPS beat(2)-140.27%
Max EPS beat(2)16.06%
EPS beat(4)3
Avg EPS beat(4)-0.81%
Min EPS beat(4)-140.27%
Max EPS beat(4)87.62%
EPS beat(8)7
Avg EPS beat(8)85.65%
EPS beat(12)9
Avg EPS beat(12)29.05%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.13%
Min Revenue beat(2)-24.47%
Max Revenue beat(2)-5.8%
Revenue beat(4)1
Avg Revenue beat(4)-10.43%
Min Revenue beat(4)-24.47%
Max Revenue beat(4)1.11%
Revenue beat(8)4
Avg Revenue beat(8)-4%
Revenue beat(12)7
Avg Revenue beat(12)-1.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1.96%
EPS NQ rev (3m)-8.33%
EPS NY rev (1m)0%
EPS NY rev (3m)23.08%
Revenue NQ rev (1m)-0.9%
Revenue NQ rev (3m)0.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 516.44
P/S 18.98
P/FCF N/A
P/OCF N/A
P/B 7.02
P/tB 14.73
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)0.05
Fwd EY0.19%
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.37
BVpS3.71
TBVpS1.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.21%
ROE -7.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.88%
FCFM N/A
ROA(3y)-5.28%
ROA(5y)-5.94%
ROE(3y)-6.12%
ROE(5y)-8.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.08%
GM growth 5YN/A
F-Score1
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 99.62%
Cap/Sales 11.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.6
Quick Ratio 3.91
Altman-Z 23.79
F-Score1
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)84.99%
Cap/Depr(5y)70.46%
Cap/Sales(3y)11.41%
Cap/Sales(5y)11.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
EPS Next Y39.4%
EPS Next 2Y48.39%
EPS Next 3Y26.83%
EPS Next 5Y27.84%
Revenue 1Y (TTM)18.16%
Revenue growth 3Y46.35%
Revenue growth 5YN/A
Sales Q2Q%4.71%
Revenue Next Year13.93%
Revenue Next 2Y18.86%
Revenue Next 3Y16.25%
Revenue Next 5Y17.43%
EBIT growth 1Y-82.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.53%
EBIT Next 3Y58.32%
EBIT Next 5Y46.35%
FCF growth 1Y4.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.22%
OCF growth 3YN/A
OCF growth 5YN/A